PCN64 Cost-Effectiveness of Pembrolizumab (KEYTRUDA®) in Combination with Chemotherapy for First-LINE Treatment of Metastatic Squamous NON-SMALL Cell LUNG Cancer (NSCLC) in France

Saved in:
Bibliographic Details
Published in:Value in health 2020-12, Vol.23, p.S433-S433
Main Authors: Chouaid, C., Bensimon, L., Tardu, J., Millier, A., Insinga, R., Rai, A., Levy-Bachelot, L., Levy, P.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2020.08.201